A dual receptors-targeting and size-switchable "cluster bomb" co-loading chemotherapeutic and transient receptor potential ankyrin 1 (TRPA-1) inhibitor for treatment of triple negative breast cancer.

Wang, Yashi

A dual receptors-targeting and size-switchable "cluster bomb" co-loading chemotherapeutic and transient receptor potential ankyrin 1 (TRPA-1) inhibitor for treatment of triple negative breast cancer. [electronic resource] - Journal of controlled release : official journal of the Controlled Release Society 05 2020 - 71-83 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1873-4995

10.1016/j.jconrel.2020.02.010 doi


Animals
Ankyrins
Cell Line, Tumor
Doxorubicin
Drug Carriers
Humans
Mice
Micelles
TRPA1 Cation Channel--antagonists & inhibitors
Triple Negative Breast Neoplasms--drug therapy